Temporal Trends and Early Outcomes of Transcatheter versus Surgical Mitral Valve Repair in Atrial Fibrillation Patients

Table 5

Factors associated with 30-day readmission after TMVR.

Variables	Univariate logistic regression			Multivariate logistic regression
	OR	95% CI	value	OR	95% CI	value
LOS>5 day	2.69	2.27–3.18	<0.001	2.15	1.75–2.65	<0.001
Renal disease	1.48	1.26–1.74	<0.001	1.37	1.14–1.64	<0.001
Heart failure with reduced ejection fraction	1.92	1.33–2.77	<0.001	1.87	1.25–2.78	0.0022
Chronic pulmonary disease	1.5	1.26–1.78	<0.001	1.34	1.1–1.62	0.003
Female	1.26	1.07–1.48	<0.001	1.23	1.04–1.46	0.014
Dementia	1.95	1.21–3.12	0.01	1.68	1.03–2.76	0.040
Elective	1.99	1.68–2.36	<0.001	1.22	0.99–1.5	0.059
Heart failure with preserved ejection fraction	1.9	1.09–3.32	0.02	1.39	0.78–2.47	0.267
Charlson comorbidity index	1.13	1.09–1.18	<0.001	1.02	0.95–1.09	0.640
Age>75	0.91	0.77–1.07	0.24
AIDS	2.72	0.5–14.85	0.25
Alcohol use	1.08	0.13–9.3	0.94
Anemia	1.29	0.9–1.85	0.16
Cerebrovascular disease	1.12	0.8–1.57	0.5
Diabetes	1.02	0.82–1.27	0.86
Dyslipidemia	0.87	0.74–1.02	0.09
Metastatic solid tumor	1.94	0.7–5.41	0.2
Liver disease	1.06	0.65–1.75	0.81
Myocardial infarction	1.06	0.82–1.37	0.66
Obesity	1.01	0.8–1.28	0.91
Paraplegia	1.56	0.71–3.43	0.27
Paroxysmal AF	1.05	0.89–1.23	0.59
Peptic ulcer disease	1.48	0.99–2.2	0.05
Peripheral vascular disease	1.07	0.87–1.31	0.54
Prior CABG	0.87	0.65–1.17	0.37
Prior PCI	0.78	0.59–1.02	0.07
Prior PPM/ICD	1.03	0.83–1.28	0.81
Prior stroke	1.16	0.91–1.48	0.24
Rheumatic disease	0.74	0.22–2.47	0.62
Smoke	0.87	0.73–1.03	0.11

OR: odds ratio; CI: confidence interval; LOS: length of stay; AF, atrial fibrillation; CABG: coronary artery bypass graft surgery; SMVR, surgical mitral valve repair; TMVR: transcatheter mitral valve repair; PPM: permanent pacemaker implant; ICD: implantable cardioverter defibrillator.